Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock $0.001 par value
-
Shares outstanding
-
28M
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
1.63M
-
Shares change
-
+586K
-
Total reported value, excl. options
-
$5.76M
-
Value change
-
+$1.49M
-
Number of buys
-
14
-
Number of sells
-
-11
-
Price
-
$3.53
Significant Holders of GEOVAX LABS, INC. - Common Stock $0.001 par value (BLCM) as of Q4 2020
31 filings reported holding BLCM - GEOVAX LABS, INC. - Common Stock $0.001 par value as of Q4 2020.
GEOVAX LABS, INC. - Common Stock $0.001 par value (BLCM) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.63M shares
of 28M outstanding shares and own 5.82% of the company stock.
Largest 10 shareholders include Ikarian Capital, LLC (500K shares), BAKER BROS. ADVISORS LP (249K shares), VANGUARD GROUP INC (169K shares), SABBY MANAGEMENT, LLC (160K shares), BlackRock Inc. (103K shares), Anson Funds Management LP (99.1K shares), GSA CAPITAL PARTNERS LLP (66.6K shares), BOOTHBAY FUND MANAGEMENT, LLC (53K shares), GEODE CAPITAL MANAGEMENT, LLC (31.4K shares), and CITADEL ADVISORS LLC (27K shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.